Successful pregnancy in a cystic fibrosis patient with a severe impairment of lung function receiving Elexacaftor-Tezacaftor-Ivacaftor

Respir Med Case Rep. 2022 Nov 8:40:101776. doi: 10.1016/j.rmcr.2022.101776. eCollection 2022.

Abstract

Before the arrival of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulators women with CF and impaired lung function were experiencing a high risk of complications and mortality during and the years after pregnancy. The arrival of the highly efficient CFTR modulator, Elexacaftor-Tezacaftor-Ivacaftor (ETI) resulted in an improvement of lung function, quality of life and fertility. Here we report a case of successful pregnancy and uncomplicated delivery for a CF patient with severely impaired lung function receiving ETI prior to conception.

Keywords: Cystic fibrosis; Elexacaftor-Tezacaftor-Ivacaftor; Impaired lung function; Pregnancy.

Publication types

  • Case Reports